Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 15, 2020
DAVITA INC. (NYSE: DVA) ("DaVita"), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care...
-
Sep 8, 2020
DaVita Inc. announced today that its Board of Directors appointed a new independent director, Mr. Shawn Guertin, to join the Board, effective Sept. 15. Mr. Guertin joins the Board with nearly 35...
-
Aug 27, 2020DaVita urges patients to have an emergency plan in place for dialysis treatment
In response to Hurricane Laura, DaVita Kidney Care has opened its dialysis centers in Texas, Louisiana, Alabama and Mississippi to anyone who needs treatment, regardless of where those patients...
-
Aug 20, 2020DaVita Clinical Research investigating presence of COVID-19 antibodies and genetic contributions to infection severity in patients
DaVita Clinical Research (DCR), a subsidiary of DaVita Inc., has begun enrollment on two clinical research trials to study how COVID-19 affects people with end stage kidney disease (ESKD) who are...
-
Aug 17, 2020
DaVita Inc. (NYSE: DVA) ("DaVita"), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care...
-
Aug 13, 2020The "Bridge to Your Dreams" program offers DaVita clinical teammates the opportunity to receive financial support to help them earn nursing degrees
DaVita has expanded a tuition and support program for its clinical teammates to help them earn an associate's degree in nursing. The program, named Bridge to Your Dreams, includes comprehensive...
-
Aug 11, 2020
DaVita Inc. (NYSE: DVA) announced today that its Board of Directors appointed a new independent director, Ms. Paula A. Price, to join the Board, effective September 1, 2020. "We are very excited...
-
Aug 6, 2020
DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the "2031 notes")....
-
Aug 6, 2020
DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the "2031 notes"), subject to...
-
Jul 30, 2020
During the second quarter of 2020, DaVita (NYSE: DVA) remained focused on its top priorities, the safety and care of its patients, caregivers, teammates and physician partners. In the face of the...